Wim A Wuyts
Overview
Explore the profile of Wim A Wuyts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
2762
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vulsteke J, Lenaerts J, Dillaerts D, Verschueren P, Wuyts W, De Crem N, et al.
Autoimmun Rev
. 2025 Feb;
24(5):103764.
PMID: 39933610
No abstract available.
2.
Moen E, Prior T, Kreuter M, Wuyts W, Molina-Molina M, Wijsenbeek M, et al.
BMC Pulm Med
. 2025 Feb;
25(1):59.
PMID: 39901224
Background: Advances in the field of genetics of interstitial lung diseases (ILDs) have led to the recent consensus statements made by expert groups. International standards for genetic testing in ILD...
3.
Delameillieure A, Somogyi V, Schenk S, Toreyin N, Stenzel N, Van Bulck L, et al.
Eur Respir Rev
. 2025 Jan;
34(175.
PMID: 39843158
Introduction: People with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF) have a high symptom burden and a poor health-related quality of life (HRQoL). Despite efforts...
4.
Wuyts W, Bonella F, Chaudhuri N, Varone F, Antin-Ozerkis D, Song J, et al.
Lung
. 2025 Jan;
203(1):25.
PMID: 39789408
Purpose: In the INBUILD trial in patients with progressive pulmonary fibrosis (PPF), nintedanib slowed the decline in forced vital capacity (FVC) versus placebo, with a safety profile characterised mainly by...
5.
Vermaut A, Geudens V, Willems L, Aerts G, Kerckhof P, Hooft C, et al.
Ann Am Thorac Soc
. 2024 Dec;
PMID: 39700513
RATIONALE+OBJECTIVE/ Cystic fibrosis (CF) is characterized by bronchiectasis on imaging, while functionally evolving towards obstructive impairment. Despite its assumed importance in CF, small airway remodeling and its relation to bronchiectasis,...
6.
Song Q, Singh A, McDonough J, Adams T, Vos R, De Man R, et al.
PLoS Comput Biol
. 2024 Dec;
20(12):e1012632.
PMID: 39700255
Age prediction based on single cell RNA-Sequencing data (scRNA-Seq) can provide information for patients' susceptibility to various diseases and conditions. In addition, such analysis can be used to identify aging...
7.
Lancaster L, Cottin V, Ramaswamy M, Wuyts W, Gisli Jenkins R, Scholand M, et al.
Ther Adv Respir Dis
. 2024 Nov;
18:17534666241287307.
PMID: 39512136
This plain language summary shares results from a clinical study called INTEGRIS-IPF that was published in the in 2024. This study looked at a medicine called (beck-so-teh-grast) as a possible...
8.
Lancaster L, Cottin V, Ramaswamy M, Wuyts W, Gisli Jenkins R, Scholand M, et al.
Am J Respir Crit Care Med
. 2024 Jun;
210(4):424-434.
PMID: 38843105
Idiopathic pulmonary fibrosis (IPF) is a rare and progressive disease that causes progressive cough, exertional dyspnea, impaired quality of life, and death. Bexotegrast (PLN-74809) is an oral, once-daily, investigational drug...
9.
Behr J, Salisbury M, Walsh S, Podolanczuk A, Hariri L, Hunninghake G, et al.
Am J Respir Crit Care Med
. 2024 Mar;
210(4):392-400.
PMID: 38484133
No abstract available.
10.
Ford P, Kreuter M, Brown K, Wuyts W, Wijsenbeek M, Israel-Biet D, et al.
ERJ Open Res
. 2024 Jan;
10(1).
PMID: 38288082
Background: There is no standard definition of respiratory-related hospitalisation, a common end-point in idiopathic pulmonary fibrosis (IPF) clinical trials. As diverse aetiologies and complicating comorbidities can present similarly, external adjudication...